Thus, our data above suggest that Ashitaba ameliorates NAFLD by regulating FXR/RXR, NF-κB, AMPK, and PPAR signaling pathways. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.